Peng, Yi – Trademark Portfolio
Entity Type: 16
Peng, Yi holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 25 (Clothing) across 5 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include PYMIN, COOLKIN, MOSSLAY, PSLALAE, and KUERUSOR. The owner is based in Buffalo, WY.
412 North Main Street, Suite # 100
Buffalo, WY 82834
Showing of trademarks Trademarks
Trademark Classifications
Peng, Yi's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Machines and machine tools; motors and engines; machine coupling and transmission components
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Peng, Yi have?
Peng, Yi has 9 U.S. trademarks filed with the USPTO. Of these, 6 registered, 3 abandoned.
What trademark classes does Peng, Yi file in?
Peng, Yi files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 25 (Clothing), Class 3 (Cosmetics & Cleaning), Class 7 (Machinery), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Peng, Yi's most well-known trademarks?
Peng, Yi's registered trademark portfolio includes well-known marks such as PYMIN, COOLKIN, MOSSLAY, PSLALAE, and KUERUSOR. These are among 6 currently registered trademarks in the portfolio.
What is Peng, Yi's trademark registration success rate?
Peng, Yi has a 67% trademark registration rate, with 6 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.